Strategies for using in vitro screens in drug metabolism

被引:101
作者
Plant, N [1 ]
机构
[1] Univ Surrey, Sch Biomed & Mol Sci, Guildford GU2 7XH, Surrey, England
关键词
D O I
10.1016/S1359-6446(03)03019-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In vitro assays are increasingly being used in drug metabolism studies to screen novel chemicals. Their advantages are twofold: first, they allow testing early in the drug discovery phase, providing important information on chemical characteristics; second, human cells or cell constituents can be utilized, increasing the relevance to man. However, the process of isolation, transformation or storage of these cell systems may alter their phenotype (and, in the case of tumour-derived cell lines, genotype as well). A review of the systems currently employed shows that, whereas all systems have their own caveats, it is possible to find an appropriate system for any particular question that is asked.
引用
收藏
页码:328 / 336
页数:9
相关论文
共 63 条
[1]  
Allen SW, 2001, DRUG METAB DISPOS, V29, P1074
[2]   IMPROVED BACTERIAL TEST SYSTEM FOR DETECTION AND CLASSIFICATION OF MUTAGENS AND CARCINOGENS [J].
AMES, BN ;
LEE, FD ;
DURSTON, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (03) :782-786
[3]   NOVEL EXOGENOUS HEME-DEPENDENT EXPRESSION OF MAMMALIAN CYTOCHROME-P450 USING BACULOVIRUS [J].
ASSEFFA, A ;
SMITH, SJ ;
NAGATA, K ;
GILLETTE, J ;
GELBOIN, HV ;
GONZALEZ, FJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 274 (02) :481-490
[4]   Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1 [J].
Auyeung, DJ ;
Kessler, FK ;
Ritter, JK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 191 (02) :156-166
[5]   Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes [J].
Bachmann, K ;
Byers, J ;
Ghosh, R .
XENOBIOTICA, 2003, 33 (05) :475-483
[6]   CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide [J].
Bidstrup, TB ;
Bjornsdottir, I ;
Sidelmann, UG ;
Thomsen, MS ;
Hansen, KT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) :305-314
[7]   Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME [J].
Binda, D ;
Lasserre-Bigot, D ;
Bonet, A ;
Thomassin, M ;
Come, MP ;
Guinchard, C ;
Bars, R ;
Jacqueson, A ;
Richert, L .
TOXICOLOGY IN VITRO, 2003, 17 (01) :59-67
[8]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[9]  
Bowen WP, 2000, DRUG METAB DISPOS, V28, P781
[10]   An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons [J].
Brandon, EFA ;
Raap, CD ;
Meijerman, I ;
Beijnen, JH ;
Schellens, JHM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (03) :233-246